Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Clinical Trials01:16

Clinical Trials

7.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
7.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

173
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
173
Blinding01:11

Blinding

2.6K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.6K
Randomized Experiments01:13

Randomized Experiments

7.2K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.2K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Virtual Reality Simulation in Postgraduate Pediatric Critical Care Training Based on Trainee Perceptions in London: Exploratory Mixed Methods Study.

JMIR formative research·2026
Same author

Sodium Bicarbonate for Critically Ill Adults with Metabolic Acidosis and Shock.

The New England journal of medicine·2026
Same author

Corrigendum to "Temporal trends in sepsis hospitalisations and mortality in Aotearoa New Zealand, 2000-2019: a population-based study" [The Lancet Regional Health - Western Pacific, Volume 65, December 2025, 101767].

The Lancet regional health. Western Pacific·2026
Same author

Opportunities and Challenges of Generative AI in Postgraduate Health Professions Education Assessments From Educator and Learner Perspectives: Qualitative Study.

JMIR formative research·2026
Same author

Early differential protein expression in blood and bronchoalveolar fluid among ARDS phenotypes.

Scientific reports·2026
Same author

Considerations raised during the regulatory and ethics review of platform clinical trials in infectious diseases.

Contemporary clinical trials communications·2026

Related Experiment Video

Updated: Sep 8, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K

Hurdles for the Delivery of Multinational Randomized Clinical Trials.

Denise van Hout1, Paul Mouncey2, David Harrison2

  • 1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.

JAMA Network Open
|July 2, 2025
PubMed
Summary

Ethical, administrative, regulatory, and logistical (EARL) procedures significantly delayed clinical trials. The UK demonstrated substantially faster contract completion and approval times compared to other European countries, especially during the COVID-19 pandemic.

More Related Videos

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.4K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.0K

Related Experiment Videos

Last Updated: Sep 8, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.4K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.0K

Area of Science:

  • Clinical trial operations
  • Regulatory science
  • Public health preparedness

Background:

  • Ethical, administrative, regulatory, and logistical (EARL) procedures often impede clinical trial delivery.
  • Quantifying these barriers is crucial for identifying areas for improvement in trial efficiency.

Purpose of the Study:

  • To identify and quantify EARL hurdles in clinical trial delivery.
  • To compare these hurdles before and during the COVID-19 pandemic across European countries.

Main Methods:

  • A cohort study analyzed data from the Randomized Embedded Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia.
  • Compared EARL procedures for multiple protocols across 19 European countries in pre-pandemic and pandemic periods.
  • Analyzed contract and protocol submission data, with time to site contract completion, time to regulatory and ethical approval (TTA), and time to first patient in (FPI) as key metrics.

Main Results:

  • In the UK, contract completion times decreased by 97% during the pandemic (median 5 days vs. 196 days pre-pandemic).
  • Non-UK countries showed less improvement in contract completion (183 days vs. 224 days pre-pandemic).
  • During the pandemic, UK TTA was significantly faster (median 8 days) than in non-UK countries (median 115 days), with UK trials also reaching first patient in 3 months faster.

Conclusions:

  • EARL procedures are lengthy and vary significantly between European countries due to differing regulatory interpretations.
  • The UK exhibited markedly faster trial initiation processes compared to other European nations.
  • Streamlining EARL processes across Europe is essential for enhancing clinical trial efficiency, particularly during public health emergencies.